Precision Medicine: The new R&D paradigm



Precision Medicine: The New R&D Paradigm


Precision medicine has significantly progressed in the last several years as it has become possible to find more tailored treatments for patients based on biomarker testing.

As a result, drug developers are now relying less on the search for the next blockbuster drug, but there are serious challenges to this change in focus as there is not yet an established business model for success with precision medicine.

Read this white paper to find out:

  • What the industry must do to adapt to this new reality
  • Ways that innovative government and university initiatives are advancing precision medicine
  • How companies have benefited by applying a well-research biomarker approach

Read the white paper now and learn more.

To access the complimentary white paper 'Precision Medicine: The new R&D paradigm', please fill in the form below.

By submitting this form you also agree to receive information relevant to your interests from Elsevier B.V. and its affiliates worldwide. You can opt-out at any time by following the instructions given in the email messages you receive.


Elsevier's R&D Solutions supporting 'Precision Medicine: The New R&D Paradigm'

Reaxys

Drive successful early drug discovery by providing chemists the shortest path to relevant literature, patent information, valid compound properties, and experimental procedures.

Learn more about Reaxys
Contact a Reaxys expert

Reaxys Medicinal Chemistry

Achieve more efficient hit identification and lead optimization by providing chemists the shortest path to normalized compound–target affinity data and comprehensive pharmacokinetic, efficacy, toxicity, safety and metabolic profiles.
Learn more about Reaxys Medicinal Chemistry
Contact a Reaxys Medicinal Chemistry expert

PharmaPendium

Make more informed drug development decisions on safety and efficacy, risk assessments and mitigation, and study designs by providing researchers with searchable FDA/EMA drug approval documents and comparative drug safety data.
Learn more about PharmaPendium
Contact a PharmaPendium expert

Embase

Uncover drug-disease relationships and drug-drug interactions by increasing the discovery of biomedical evidence and providing comprehensive relevant, up-to-date biomedical information.

Learn more about Embase
Contact a Embase expert

Pathway Studio

Streamline target and biomarker identification and drug repurposing by providing biological researchers with greater insight into the mechanisms of disease and facilitating the interpretation of experimental data.
Learn more about Pathway Studio
Contact a Pathway Studio expert

Professional Services

Drive innovative pharmaceutical research by resolving challenges with data quality and integration and making data easier for researchers to compare, analyze, interpret and share.

Learn more about Professional Services
Contact a Professional Services expert

ScienceDirect

Help researchers understand the entire breadth of research surrounding a disease by helping them more effectively and efficiently search authoritative, full-text scientific, technical and health content.

Learn more about ScienceDirect
Contact a ScienceDirect expert

Scopus

Detect trends, find partnerships and identify experts to stay on the cutting edge of research through the world’s largest abstract and citation database of peer-reviewed literature, including tools to track, analyze and visualize research.
Learn more about Scopus
Contact a Scopus expert